Profile data is unavailable for this security.
About the company
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, Australia, New Zealand, Asia (excluding China, which includes Hong Kong but excludes Taiwan), Africa and the Middle East (excluding Turkey). Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.
- Revenue in AUD (TTM)2.17m
- Net income in AUD-5.55m
- Incorporated2017
- Employees--
- LocationHydration Pharmaceuticals Co LtdLevel 2,, 6 Palmer Parade,, CremorneMELBOURNE 3121AustraliaAUS
- Websitehttps://hydralyte.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evofem Biosciences Inc | 24.99m | -7.83m | 1.63m | 32.00 | -- | -- | -- | 0.065 | -0.058 | -0.058 | 0.0111 | -0.5661 | 0.9392 | 2.25 | 3.61 | 553,937.50 | -28.79 | -177.41 | -- | -- | 80.05 | 69.60 | -30.66 | -602.27 | 0.0797 | -0.2439 | -- | -- | 6.28 | -- | -117.93 | -- | -38.87 | -- |
| Ortin Global Ltd | 20.60k | -147.43k | 1.64m | 3.00 | -- | 8.13 | -- | 79.72 | -1.17 | -1.17 | 0.1634 | 1.60 | 0.0338 | 8.84 | 0.1503 | 442,000.00 | -24.15 | -6.49 | -40.57 | -13.44 | 34.01 | 35.99 | -715.61 | -33.91 | 2.08 | -- | 0.4171 | -- | -83.79 | -71.96 | 89.47 | -- | -- | -- |
| American Green Inc | -141.00bn | -141.00bn | 1.84m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Hydration Pharmaceuticals Co Ltd | 2.17m | -5.55m | 1.94m | -- | -- | 0.4504 | -- | 0.8914 | -0.022 | 0.0311 | 0.0077 | 0.01 | 0.3189 | 0.4291 | 1.99 | -- | -81.35 | -80.15 | -165.85 | -113.93 | 49.37 | 46.59 | -255.13 | -125.35 | 2.43 | -6.06 | 0.00 | -- | -25.48 | 1.58 | 21.50 | -- | -- | -- |
| Procyon Corp | 7.03m | -441.30k | 2.16m | 19.00 | -- | 0.7027 | -- | 0.307 | -0.0387 | -0.0387 | 0.6138 | 0.2817 | 1.47 | 2.32 | 9.90 | 262,338.40 | -10.08 | 1.19 | -12.70 | 1.44 | 78.07 | 74.40 | -6.84 | 0.8691 | 2.41 | -- | 0.00 | -- | 6.35 | 3.53 | -367.38 | -- | 17.32 | -- |
| Saroja Pharma Industries India Ltd | 11.40m | 197.10k | 2.25m | 12.00 | 11.38 | 0.8922 | 10.43 | 0.1976 | 3.17 | 3.17 | 183.12 | 40.41 | -- | -- | -- | 61,135,500.00 | -- | 5.16 | -- | 11.56 | 6.85 | 10.01 | 1.73 | 2.05 | 1.19 | 2.00 | 0.3926 | -- | 32.11 | 25.76 | 17.75 | 45.07 | 157.98 | -- |
| Holder | Shares | % Held |
|---|---|---|
| PURE Asset Management Pty Ltd.as of 25 May 2024 | 60.95m | 14.15% |
| Regal Funds Management Pty Ltd.as of 08 Jul 2025 | 29.12m | 6.76% |
